Stock Events

Stock Events

Akero Therapeutics (AKRO) Q3 2024 Earnings

9AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.99

-0.89

-0.78

-0.68

Details

Expected EPS

-0.829662

Actual EPS

-0.81

Surprise EPS

0.02

Surprise Percent

+2.37%

Description

Akero Therapeutics (AKRO) has reported earnings of -0.81 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.